Specializes in the diagnosis and treatment of complex and intractable diseases in otorhinolaryngology, such as otitis media, head and facial tumors, including surgical procedures for thyroid tumors and postoperative systematic management. Graduated from Shanghai Second Medical University with a Bachelor of Medicine in 1990, directly pursued a Master's degree in the Department of Otorhinolaryngology at the affiliated Renji Hospital of the same university and stayed to work in this department, obtained a Doctor of Medicine degree in 2007. Qualified as a Chief Physician in 2005, and currently serves as a Chief Physician in the Department of Otorhinolaryngology at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Has long been engaged in clinical, scientific research, and teaching work in otorhinolaryngology. While comprehensively coordinating the diagnosis and treatment of otorhinolaryngological diseases, has conducted in-depth research in subspecialties. As an expert in the field of audiology, possesses mastery of the current frontiers in hearing-related basic research and clinical translation. Has carried out a series of work in the pathogenesis and clinical practice of head and neck malignant tumors. The most significant research findings include using molecular-level alterations and phenotypic changes theories to demonstrate the safe margin range for surgical resection of malignant tumors such as laryngeal cancer, and that human papillomavirus is closely related to the occurrence of laryngeal cancer. In the diagnosis and treatment of sleep-related diseases such as snoring, keeps pace with the most advanced research findings and clinical applications. For certain complex chronic diseases in otorhinolaryngology such as pharyngitis, rhinitis, and tinnitus, classifies them according to etiology and pathology, establishes unique diagnostic and therapeutic approaches of subclinical same-symptom different-treatment, provides targeted treatment, and achieves good results. Was among the earlier in China to promote and apply minimally invasive surgery, enabling the relevant surgical time, blood loss, hospitalization duration, and healing rate to improve several times compared with traditional surgery, achieving minimal complications and maximum disease cure rate for patients. Has consistently maintained a high medical safety rate over more than thirty years of medical practice. In terms of scientific research, has published more than 50 papers and participated in the compilation of 7 monographs.